Sales, comps rise for Fred’s in July
MEMPHIS, Tenn. — Fred’s on Wednesday posted a 5% increase in total sales for the four-week period ended July 28 to $136.7 million, the discount retailer announced.
Comparable-store sales for the month increased 1.2%, versus a decrease of 0.5% in the same period last year.
"The increase for the month primarily reflected promotions aimed at driving customer traffic, which worked well for us and resulted in a significant improvement from recent months," Fred’s CEO Bruce Efird said. Pharmacy was a standout in July, Efird added, with continued growth in script counts. "The sales performance of our newer stores and pharmacies continued to exceed expectations, extending a trend we have seen throughout this year."
Fred’s total sales for the second quarter of fiscal 2012 increased 4% to $470.7 million. On a comparable-store basis, second quarter sales decreased 1%, compared with a decline of 0.4% in the same period last year.
Pepperidge Farm gets new president
CAMDEN, N.J. — Campbell’s confirmed that a new leader will take over the company’s Pepperidge Farm business.
Irene Chang Britt, who has worked at Campbell’s since 2005, will replace Pat Callaghan as president of Pepperidge Farm. Britt is the first woman to lead Pepperidge Farm since company founder Margaret Rudkin presided over the business from 1937 to 1966. Pepperidge Farm was acquired by Campbell’s in 1961.
Britt will be based at Pepperidge Farm’s headquarters in Norwalk, Conn., and will report to Campbell’s president and CEO Denise Morrison.
"I am thrilled to step into my new role as the leader of such a beloved brand," Britt said. "Pepperidge Farm’s success has been built on smart and successful innovation and by thinking in real consumer terms. Thanks to Pat’s leadership, Pepperidge Farm has become a leader in snacking, and I’m eager to hit the ground running and to help the team take the business to the next level."
GSK begins shipping FluLaval, Fluarix for 2012-2013 flu season
PHILADELPHIA — Following regulatory approval by the Food and Drug Administration’s Center for Biologics Evaluation and Research, GlaxoSmithKline confirmed it has begun shipping the first lots of its 2012-2013 seasonal influenza vaccines to healthcare providers and Centers for Disease Control and Prevention distribution centers.
GSK said FluLaval is approved for use in adults ages 18 years and older to help protect against influenza disease caused by the virus subtypes A and B contained in the vaccine. GSK said its other vaccine, Fluarix, is approved for use in adults, as well as children ages 3 years and older.
"The three strains of influenza virus in the seasonal influenza vaccine can change from year-to-year based on estimates of the strains that will circulate in the upcoming season," said Leonard Friedland, VP and head of clinical/medical affairs for GSK North America Vaccine Development. "This is a key reason why the CDC recommends everyone six months of age and older gets an influenza vaccination every year. For the 2012-2013 influenza season, two of the three strains have been changed compared to last year’s formulation."